All SARS-CoV-2 articles – Page 25
-
NewsMap the coronavirus spike protein for insight into vaccine development
A new study has found that the fusion peptide in the spike protein plays a more invasive role in fusing the virus to the cell than previously thought, which is significant in understanding how infection occurs.
-
NewsStudy helps explain SARS-CoV-2 variants’ rapid spread
Omicron variants, which circulated quickly around the globe, bind to cells more avidly and evade antibodies more efficiently than earlier variants, new research reveals.
-
NewsTexas Biomed partners with Scancell to test novel COVID vaccine
A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed).
-
NewsAttack on Mac1 Covid protein may lead to longer lasting live-attenuated vaccine
Research could hasten development of a new class of vaccines aimed at SARS-CoV-2, the virus that causes COVID-19.
-
NewsN-protein research reveals role of human body temperature in Covid proliferation
Researchers shed light on a pivotal part in the RNA-binding mechanism of the nucleocapsid protein (N) – SARS-CoV-2 probably uses human body temperature for its proliferation strategy.
-
NewsCommon cold virus exposure may help usher in immunity to Covid
Exposure to common cold-causing coronaviruses may contribute to pre-existing immunity to COVID-19, according to a new study.
-
NewsMolnupiravir dose of human effect size-equivalent blocks Covid transmission in ferrets
Two oral drugs provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models, but only molnupiravir efficiently blocked SARS-CoV-2 transmission when administered at a human effect size-equivalent dose.
-
NewsModulating type 1 Interferon may expand treatment options for COVID-19
Researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 Interferon (IFN-I), one of the body’s initial defenses against infection, impacts SARS-CoV-2 viral replication and disease progression.
-
NewsNew Drosophila toolkit to help reveal how Covid-19 virus impacts human health
Researchers have developed a toolkit of <i>Drosophila melanogaster</i> COVID-19 resources to study how viral and human proteins interact, with the goal of developing therapies for symptoms caused by existing and new strains.
-
NewsModerna is safest, most effective mRNA vaccine against COVID-19 for older adults
A study of older US adults found that the risk of negative effects of both mRNA vaccines is exceptionally low, but lowest with the Moderna vaccine.
-
NewsAI-based wastewater sampling predicts COVID hospital admissions
Researchers have developed an accurate prediction tool for estimating COVID-19 hospital admissions, using an Artificial Intelligence (AI) based system with wastewater sampling.
-
NewsBreath test rapidly detects COVID-19 virus
Scientists have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides results in less than a minute.
-
NewsCOVID-19 vaccination reduces severity and mortality after breakthrough infections
Among individuals recently infected with SARS-CoV-2, those who were fully vaccinated had lower concentrations of almost all inflammation markers (cytokines and chemokines) than those who were unvaccinated in the short-term and long-term after symptomatic SARS-CoV-2 infection.
-
NewsNewly discovered antibodies can neutralize COVID-19 variants
Scientists have isolated potent neutralizing antibodies from a COVID-19 vaccinated SARS survivor that exhibited remarkable breadth against known sarbecoviruses.
-
NewsSmaller magnetic beads with superior magnetic moment capture Covid virus more quickly
Scientists have developed a more efficient way to test SARS-CoV-2 Virus with a novel nano-immune magnetic bead (Mal-IMB) that can efficiently be bound to the pseudovirus in the study of protein biomimetic mineralization and synthesized into magnetic nanoparticles.
-
NewsFar UVC light could have disinfection potential against Covid variants
Scientists have investigated the inactivation efficacy of different UV wavelengths and assessed the safety profile for effective management of COVID-19 risks.
-
NewsSpike protein mutants with low binding affinity usher in new Covid vaccine
Researchers have succeeded in producing a new vaccine against the SARS-CoV-2 coronavirus by identifying spike protein mutants that lack binding affinity.
-
NewsInterferon could help reduce the spread of COVID-19
Results of an innovative clinical trial have shown that the drug interferon could help reduce the spread of COVID-19 from a positive person to their household contacts, with the study helping to inform treatment options for a future pandemic.
-
NewsFly toolkit created for investigating COVID-19 infection mechanisms
A new ‘fly-to-bedside’ resource offers a shortcut for developing drug therapies needed for long COVID and future coronavirus outbreaks.
-
NewsScent dogs can detect COVID-19 more rapidly and accurately than current tests
Scent dogs may represent a cheaper, faster and more effective way to detect COVID-19, and could be a key tool in future pandemics, a new review of recent research suggests.